The tumor microenvironment (TME) further compounds resistance through the presence of myeloid-derived suppressor cells (MDSCs), tumor-associated macrophages (TAMs), and vascular endothelial growth factor (VEGF). The gene discussed is VEGFA; the disease is neoplasm.